跳至主要内容
临床试验/jRCT2071240058
jRCT2071240058进行中(未招募)不适用

Clinical Pharmacology Study of NS-229 in Healthy female subjects (Phase I Study) (Drug-Drug Interaction Study with combined oral contraceptive)

Nippon Shinyaku Co., Ltd.0 个研究点目标入组 25 人开始时间: 2024年10月22日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
25
主要终点
Plasma concentrations of combined oral contraceptive

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study
干预模型
Single Assignment
主要目的
Other
盲法
Open(masking Not Used)

入排标准

年龄范围
20age old over 至 40age old not(—)
性别
Female

入选标准

  • Provided written informed consent
  • Japanese female subjects
  • Body mass index (BMI) >=18.5 and <25.0 kg/m2 at the time of screening tests and hospitalization

排除标准

  • Sublects who are pregnant, may become pregnant, or wish to become pregnant during the trial period
  • Subjects who are breastfeeding
  • Subjects who have not confirmed a regular menstrual cycle at the time of screening test
  • Subjects who are irregular bleeding

结局指标

主要结局

Plasma concentrations of combined oral contraceptive

Plasma concentrations of combined oral contraceptive

PK parameters of combined oral contraceptive

PK parameters of combined oral contraceptive

Plasma concentrations of NS-229

Plasma concentrations of NS-229

PK parameters of NS-229

PK parameters of NS-229

次要结局

未报告次要终点

研究者

相似试验

Clinical Pharmacology Study of NS-229 in Healthy... | 临床试验